Oracle (NYSE:ORCL) PT Raised to $165.00 at KeyCorp

Oracle (NYSE:ORCLFree Report) had its target price hoisted by KeyCorp from $150.00 to $165.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the enterprise software provider’s stock.

ORCL has been the subject of a number of other reports. William Blair upgraded shares of Oracle from a market perform rating to an outperform rating in a research note on Tuesday, March 12th. HSBC boosted their target price on shares of Oracle from $144.00 to $155.00 and gave the company a buy rating in a research note on Wednesday, March 13th. TD Cowen boosted their target price on shares of Oracle from $145.00 to $165.00 and gave the company a buy rating in a research note on Wednesday. BMO Capital Markets boosted their target price on shares of Oracle from $126.00 to $142.00 and gave the company a market perform rating in a research note on Tuesday, March 12th. Finally, Morgan Stanley boosted their target price on shares of Oracle from $115.00 to $125.00 and gave the company an equal weight rating in a research note on Wednesday. Fourteen equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus price target of $141.50.

View Our Latest Stock Report on Oracle

Oracle Stock Down 1.2 %

ORCL opened at $138.13 on Wednesday. The company has a market cap of $379.65 billion, a P/E ratio of 37.23, a P/E/G ratio of 2.50 and a beta of 1.01. The business’s 50-day moving average price is $121.04 and its 200-day moving average price is $116.13. The company has a current ratio of 0.71, a quick ratio of 0.85 and a debt-to-equity ratio of 8.25. Oracle has a 12 month low of $99.26 and a 12 month high of $142.40.

Oracle (NYSE:ORCLGet Free Report) last announced its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). Oracle had a net margin of 19.76% and a return on equity of 223.01%. The business had revenue of $14.29 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter in the prior year, the firm earned $1.35 EPS. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis. On average, equities analysts expect that Oracle will post 5.01 EPS for the current year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Shareholders of record on Thursday, July 11th will be paid a $0.40 dividend. The ex-dividend date is Thursday, July 11th. This represents a $1.60 dividend on an annualized basis and a yield of 1.16%. Oracle’s payout ratio is presently 43.13%.

Insiders Place Their Bets

In other Oracle news, Director George H. Conrades sold 25,000 shares of the stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total transaction of $2,903,250.00. Following the completion of the transaction, the director now owns 17,836 shares of the company’s stock, valued at approximately $2,071,294.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Oracle news, Director Michael J. Boskin sold 45,000 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $117.74, for a total transaction of $5,298,300.00. Following the completion of the transaction, the director now owns 87,473 shares of the company’s stock, valued at approximately $10,299,071.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director George H. Conrades sold 25,000 shares of the stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total transaction of $2,903,250.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,071,294.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 880,000 shares of company stock worth $110,488,150. Corporate insiders own 42.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. SRN Advisors LLC lifted its holdings in shares of Oracle by 14.9% in the 1st quarter. SRN Advisors LLC now owns 12,156 shares of the enterprise software provider’s stock valued at $1,527,000 after acquiring an additional 1,572 shares during the last quarter. Mosaic Family Wealth Partners LLC lifted its holdings in shares of Oracle by 5.1% in the 1st quarter. Mosaic Family Wealth Partners LLC now owns 2,478 shares of the enterprise software provider’s stock valued at $311,000 after acquiring an additional 121 shares during the last quarter. Cypress Asset Management Inc. TX bought a new position in shares of Oracle in the 1st quarter valued at about $167,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Oracle by 4.2% in the 1st quarter. EverSource Wealth Advisors LLC now owns 12,430 shares of the enterprise software provider’s stock valued at $1,561,000 after acquiring an additional 506 shares during the last quarter. Finally, Objective Capital Management LLC bought a new position in shares of Oracle in the 1st quarter valued at about $248,000. Institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.